Related Experiment Video
Updated: Jul 2, 2026
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
[A preparative method of chronic experiment autoimmune encephalomyelitis]
Jin-jin Yan1, Guo-xiang Huang, Bo Xiao
1Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
Summary
Researchers developed a chronic experimental autoimmune encephalomyelitis (EAE) model in mice using mMOG35-55 to study multiple sclerosis. This stable EAE model shows high incidence and low mortality, suitable for further multiple sclerosis research.
Area of Science:
- Neuroimmunology
- Animal Models of Neurological Disease
Context:
- Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
- Developing reliable animal models is crucial for understanding MS pathogenesis and testing therapies.
- Chronic experimental autoimmune encephalomyelitis (EAE) serves as a key model for MS research.
Purpose:
- To establish and characterize a chronic EAE model in C57BL/6J mice.
- To utilize the synthesized myelin oligodendrocyte glycoprotein peptide (mMOG35-55) for disease induction.
- To provide a robust model for investigating the mechanisms underlying chronic multiple sclerosis.
Summary:
- Female C57BL/6J mice were immunized with mMOG35-55 and complete Freund's adjuvant.
- The induced EAE model exhibited an 83.3% incidence rate with a low mortality of 8.3%.
- Clinical symptoms peaked around 20-24 days post-immunization, transitioning into a stable chronic phase by 28-32 days.
Impact:
- The developed EAE model demonstrates high incidence, low mortality, and stability.
- This reliable model is suitable for in-depth studies of chronic multiple sclerosis.
- Facilitates further research into therapeutic strategies for multiple sclerosis.
